Effects of mineralocorticoid receptor antagonists on the progression of diabetic nephropathy

AIMS/INTRODUCTION: We aimed to evaluate the potential benefits and adverse effects of adding a mineralocorticoid receptor antagonist (MRA) to angiotensin‐converting enzyme inhibitors (ACEI) and/or angiotensin receptor blockers (ARB), as standard treatment in patients with diabetic nephropathy. MATER...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Li‐Jing, Sun, Yan‐Ni, Shan, Jian‐Ping, Jiang, Geng‐Ru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5497036/
https://www.ncbi.nlm.nih.gov/pubmed/28107779
http://dx.doi.org/10.1111/jdi.12629

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5497036/
https://www.ncbi.nlm.nih.gov/pubmed/28107779
http://dx.doi.org/10.1111/jdi.12629

Ejemplares similares